Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Liquid Biopsy 4Blood Specimen Collection 4Gemcitabine 3pembrolizumab 2Immunohistochemistry 2Cisplatin 2Capecitabine 2Base Sequence 2130-nm albumin-bound paclitaxel 2tislelizumab 1taxane 1lenvatinib 1irinotecan sucrosofate 1gemcitabine-oxaliplatin regimen 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1S 1 (combination) 1Polymerase Chain Reaction 1Platinum Compounds 1Oxaliplatin 1Nivolumab 1Microscopy, Confocal 1Methylation 1Mass Spectrometry 1Leucovorin 1Irinotecan 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Biliary Tract Neoplasms × irinotecan sucrosofate × Clear all
NCT06282120 2024-02-28

Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer

Tianjin Medical University Cancer Institute and Hospital

Unknown
30 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡